We evaluated the value of RDW as a biomarker for the clinical diagnosis of CRC compared with carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9), which are the most commonly used serum tumor markers in the diagnosis of CRC. The gene discussed is CEACAM5; the disease is colorectal carcinoma.